Light and Float Therapy for Sleep Quality

Overseen By Carolyn Ferreyra

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: West Virginia University

Disqualifiers: Mental, physical conditions, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 4

15 Participants Needed

Trial Summary

What is the purpose of this trial?

The main objective of this study is to assess the impact of implementing photobiomodulation (PBM) therapy, either localized or whole body, or dry float on sleep quality in middle-aged and elderly individuals experiencing sleep disturbance. As a secondary objective we will analyze the effect of the treatments on other indices of recovery (subjective and objective) via physiological monitoring in middle-aged and elderly individuals experiencing sleep disturbance. The study will have 2 phases: Phase 1 will last 5 weeks and will serve as baseline data collection of sleep quality. Phase 2 contains the experimental conditions and will last 13 weeks. Cognitive, behavioral, and physiological tests will be done at baseline (week 1) and at the end of experimental period (week 18). Sleep tracking data will be collected daily.

Eligibility Criteria

This trial is for middle-aged and elderly individuals aged 50-85 who are experiencing sleep disturbances but have no significant untreated medical conditions. Participants must be able to understand the study and agree to participate.

Inclusion Criteria

I am between 50 and 85 years old.

Able and willing to give informed consent

I do not have any major untreated health issues.

Exclusion Criteria

Have no mental or physical conditions that are deemed inappropriate for study participation at investigator's discretion.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Data Collection

Baseline data collection of sleep quality and initial cognitive, behavioral, and physiological tests

5 weeks

1 visit (in-person) for initial testing

Experimental Conditions

Participants undergo experimental conditions with photobiomodulation or dry float therapy, and continue daily sleep tracking

13 weeks

2-3 visits per week for therapy sessions

Follow-up

Participants are monitored for changes in sleep quality and other indices of recovery, with final cognitive, behavioral, and physiological tests

4 weeks

1 visit (in-person) for final testing

Treatment Details

Interventions

• NovoThor
• VieLight
• ZeroBody

Trial Overview The trial is testing the effects of photobiomodulation (PBM) therapy, both localized and whole body, as well as dry float therapy on improving sleep quality in participants. It includes a baseline data collection phase followed by a 13-week treatment period with daily sleep tracking.

Participant Groups

Group I: Whole-Body Photobiomodulation Experimental Treatment 1 Intervention

Light therapy in both the visible and near-infrared range (non-UV) applied to the whole body in a light pod or bed.

Group II: Localized Photobiomodulation Experimental Treatment 1 Intervention

Light therapy in both the visible and near-infrared range (non-UV) applied locally to only a specific body region.

Group III: Dry Float Experimental Treatment 1 Intervention

Simulates the effects of traditional Float-REST therapy. Instead of contact with salt water, the dry float system has a very thin membrane that cradles the body and provides a warm sensation, similar to that experienced in a traditional flotation tank.

Group IV: Control Active Control 1 Intervention

Participants in the control group will be asked to keep their normal daily routine.

Who Is Running the Clinical Trial?

West Virginia University

Lead Sponsor

Trials

192

Recruited

64,700+